Welcome to our dedicated page for Amcor SEC filings (Ticker: AMCCF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amcor plc CDI (AMCCF) SEC filings page provides access to regulatory documents for Amcor plc, whose ordinary shares trade on the New York Stock Exchange under the symbol AMCR. These filings describe Amcor as a global producer of responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products, and they document key corporate, financial and governance events.
Annual and quarterly reports such as Form 10-K and Form 10-Q (when available) contain management’s discussion of Amcor’s packaging operations, its focus on light-weighted, recyclable and reusable packaging, and the use of recycled content. They also incorporate financial statements that reflect the impact of transactions such as the merger in which Berry Global Group, Inc. became a wholly owned subsidiary of Amcor.
Current reports on Form 8-K are particularly relevant for tracking significant events. Recent 8-K filings describe the completion of euro-denominated guaranteed senior notes due 2029 and 2033 issued by Amcor UK Finance plc and guaranteed on a senior unsecured basis by Amcor plc and certain affiliates. Other 8-Ks outline shareholder voting results at the annual general meeting, including approval of an amendment to Amcor’s memorandum of association to effect a 1-for-5 reverse stock split, and provide details on the planned implementation of that reverse split and its effect on ordinary shares and CHESS Depositary Interests.
Additional 8-K disclosures cover topics such as quarterly earnings press releases, pro forma financial information related to the Berry merger, and changes in senior management, including the transition of the chief financial officer role and associated employment and settlement agreements. Together, these documents help investors understand Amcor’s capital structure, governance decisions, and major corporate actions.
On this page, filings are updated as they are released through EDGAR. AI-powered tools can help summarize lengthy documents, highlight items such as reverse stock split mechanics, senior note terms, merger-related information, and executive transitions, and make it easier to locate specific details within Amcor’s SEC reporting history.
An insider of AMCR has filed a Form 144 indicating an intention to sell 30,000 shares of common stock, with an aggregate market value of
The shares to be sold were originally acquired from the issuer as restricted stock vesting compensation in multiple grants between
Amcor plc reports significantly larger scale following its merger with Berry Global, with net sales for the quarter ended December 31, 2025 rising to $5,449 million from $3,241 million a year earlier. Six‑month net sales reached $11,194 million versus $6,594 million.
Quarterly net income attributable to Amcor increased modestly to $177 million from $163 million, but operating margin narrowed as amortization of acquired intangibles and restructuring, transaction and integration expenses rose sharply after the merger. Long-term debt (including current portion) increased to just over $15 billion, partly reflecting assumed Berry debt and new euro notes.
Operating cash flow for the first half improved to $370 million from $159 million, while capital expenditures more than doubled to $459 million. Amcor is executing the Berry integration through its “Berry Plan,” targeting substantial cost and growth synergies by fiscal 2028 and incurring elevated restructuring and integration costs in the near term.
Amcor plc filed a current report to share that it has issued a press release covering its financial results for the second quarter and first six months of fiscal year 2026. The earnings press release is provided as Exhibit 99.1 to the report.
The company specifies that this earnings information is being furnished, not filed, which affects how it is treated under U.S. securities laws. The report also includes an extensive caution about forward-looking statements, reminding readers that actual results may differ due to various risks outlined in Amcor’s prior annual report.
Amcor plc reported an insider share transaction by its Executive VP, Finance & CFO. On 12/11/2025, the officer acquired 121,065 ordinary shares of Amcor plc at a weighted average price of $8.3177 per share, according to the Form 4 table.
The filing shows that after this transaction the officer beneficially owned 121,065 ordinary shares, held directly. A footnote explains that the reported price is a weighted average, with individual trade prices ranging from $8.315 to $8.325, and notes that detailed trade-by-trade pricing information is available to the issuer, security holders, or SEC staff upon request. No derivative security transactions were reported.
Amcor plc is implementing a 1-for-5 reverse stock split of its ordinary shares previously approved by shareholders. Amcor plans to file an amendment to its memorandum of association on January 14, 2026, with shares expected to begin trading on a split-adjusted basis on January 15, 2026. Every five ordinary shares issued, outstanding or held in treasury will be combined into one share, reducing outstanding ordinary shares from approximately 2.3 billion to approximately 461 million.
The amendment will also proportionately reduce authorized ordinary and preferred shares and increase their par value to $0.05 per share; no preferred shares are currently outstanding. No fractional shares will be issued, and shareholders entitled to fractions will receive cash instead. Equity-based awards under Amcor incentive plans will be adjusted proportionately. Amcor shares will continue to trade on the NYSE under “AMCR,” and its CHESS Depositary Interests will remain listed on the ASX under “AMC.”
Amcor plc director reports small share sale to cover taxes. A director of Amcor plc filed a Form 4 disclosing the sale of 4,148 ordinary shares on 12/03/2025 at a price of $8.439 per share. The explanation states that the sale was used to cover the reporting person’s corresponding tax liability. Following this transaction, the reporting person beneficially owned 82,535 ordinary shares, held directly.
Amcor plc director reported a sale of ordinary shares in a Form 4 filing. On 12/03/2025, the reporting person sold 6,058 ordinary shares of Amcor at a price of $8.439 per share. After this transaction, the director beneficially owned 71,302 shares, held directly.
According to the explanation provided, the 6,058-share sale was used to cover the reporting person’s corresponding tax liability, resulting in 8,221 shares. No derivative securities transactions were reported in this filing.
Amcor plc reported insider equity activity by one of its directors. On December 2, 2025, the director acquired 9,317 ordinary shares through the vesting and settlement of restricted stock units, reported with transaction code "M." After this transaction, the director directly held 305,649 ordinary shares.
The filing also shows changes in derivative holdings. A block of 9,317 restricted stock units previously outstanding was settled for ordinary shares at an exercise price of $0, reducing those derivative holdings to zero. In a separate transaction on December 1, 2025, the director received a new grant of 19,907 restricted stock units, which carry no exercise price and are scheduled to vest on December 1, 2026. Each restricted stock unit represents a contingent right to receive one Amcor ordinary share upon vesting.
Amcor plc director reports equity award activity. A director of Amcor plc (AMCR) acquired 15,159 ordinary shares on 12/02/2025 through the vesting and settlement of previously granted restricted stock units, reported as a transaction code "M". Following this transaction, the director directly held 15,159 ordinary shares.
In addition, the director received a new grant of 19,907 restricted stock units on 12/01/2025. Each restricted stock unit represents a contingent right to receive one ordinary share of Amcor upon vesting, and this new award is scheduled to vest in full on 12/01/2026.
Amcor plc reported an insider equity transaction by a director. On 12/02/2025, the director exercised 14,279 restricted stock units (RSUs) into the same number of ordinary shares in a transaction coded "M". After this, the director beneficially owned 43,802 ordinary shares directly. The filing also shows a new award of 19,907 RSUs on 12/01/2025, scheduled to vest on 12/01/2026. Each RSU represents a contingent right to receive one Amcor ordinary share upon vesting.